Immunization is one of the most cost effective public health interventions to reduce child mortality. In Nigeria, vaccine-preventable diseases account for approximately 22% of childhood deaths, per year.
Internet searches were conducted in Pubmed and Medline databases and Journal hosts including African Journal Online (AJOL) and Health Inter Network Access to Research Initiative (HINARI) using specific search terms and strategies. Grey literature was obtained by soliciting reports from the federal Ministry of Health and major organizations involved immunization and from international reports.
The Nigerian health system is generally funded from federation account. Funding of immunization services is the collective responsibility of all tiers of government through statutory budgetary allocation from the Federal, State and Local Government Areas. Other sources include external donors, development partners, private sector and the community. However, these funds are disproportionately captured by the rich at the expense of the poor and by the urbanites at the expense of the rural dwellers as depicted in measles immunization coverage. There are lots of financing bottle neck in financing immunization including inadequate funds, delays in release of designated funds, inefficient use of funds, non-sustainable financing by donors, unintended consequences of Polio eradication initiative and poor integration as well as non-profitability of vaccines. Furthermore, some accountability challenges exists and include undefined roles and responsibilities within the routine immunization, unclear linkages across the different levels of government, disconnect
Introduction
Immunization is one of the most cost effective public health interventions to reduce child mortality.
(1) It involves administration of vaccines to persons to confer immunity or resistance to infectious diseases. With strategies that make it accessible to even the most hard-to-reach and vulnerable populations, immunization has been proven as a tool for controlling and eliminating lifethreatening infectious diseases. It is estimated to avert between 2 and 3 million deaths each year worldwide. (2) In Nigeria with a teeming population of 160 million, women and children under five make up two fifths of the entire population. (3) Under-five Mortality rate is 138 deaths per 1000 live births. (4) Of these, vaccine-preventable diseases account for approximately 22% of childhood deaths, amounting to over 200,000 deaths per year. (5) Out of the 6 million Nigerian children born every year in the country, more than 1 million fail to get fully vaccinated by their first birthday. (4) Immunization is one of the non-focal sectors in the Nigerian Country Support Strategy (CSS) and immunization programmes are in line with the Government commitment to invest in Primary Health Care (PHC), as a contribution to poverty alleviation.
Routine immunization schedule in Nigeria involves administration of six vaccines to children to prevent the childhood killer diseases. The vaccines include BCG, OPV, DPT, Measles, Yellow fever and Hepatitis B. In addition, Tetanus toxoid vaccine is given to women of child-bearing age (usually at ante natal clinics) and Meningitis vaccine is given to high-risk groups. However, in the year 2012, Nigeria replaced the childhood DPT and Hepatitis B vaccines with the Pentavalent vaccine which contain both the DPT, Hepatitis B and H-influenza type B vaccines. (6) In 2013 also the Pneumococcal Conjugate Vaccine (PCV) was introduced in the country however this is yet to be scaled up to all states of the federation. Plans are on the way to introduce the Rotavirus vaccine in 2017. (7) It is the policy of the Federal Government of Nigeria to provide immunization services and potent vaccines free to all population at risk of vaccine preventable diseases. This is achieved through the National Primary Health Care Development Agency (NPHCDA), other tiers of government and stakeholders. The main goal and objective of the Nigeria immunization policy is to develop and promote immunization programmes geared towards reduction of childhood morbidity and mortality through adequate immunization coverage of all atrisk populations. (1) The operational components of immunization system are vaccine supply and quality, logistics, advocacy and communication, surveillance and at the center is service delivery.
However the cost of vaccines is spiraling with new ones being introduced, including combination vaccines which are much more expensive.
The projected cost of vaccines per LGA was $167,831 in 2008 while in 2012 the cost increased to $194,697. (3) This represents a 16% increment in cost in just four years. As we aim for higher coverages in immunization, there will be higher marginal costs. Also current international financing for vaccines is not sufficient to sustain both progress in coverage and the introduction of new, crucial vaccines.
Thus immunization resource needs adequate planning, and budgeting which should include the comprehensive multi-year plan (CMYP) as well as cost and financing plan for efficient service delivery. Against the foregoing, It has become pertinent to explore how immunization is financed in Nigeria.
Methodology
This was a desk review of electronic and nonelectronic materials on immunization in Nigeria
Electronic sources of information:
Internet searches were conducted in Pubmed and Medline databases and Journal hosts including African Journal Online (AJOL) and Health Inter Network Access to Research Initiative (HINARI). Search Engines such as Google scholar were also used to obtain data.
Key words:
The key words for the search were routine immunization, financing, accountability, challenges, barriers, bottlenecks, Nigeria, Africa, Low income countries and interventions to perform a broad search. These key words were combined in different formats using OR, AND and truncation (*) to arrive at the final number of articles that were used for this manuscript. Following the PubMed search which yielded only abstracts, the full articles were searched on HINARI and AJOL. However where there was inaccessibility to full text, the abstracts were considered if they had the relevant context and content. The reference lists of the identified studies used in this review were also hand searched to uncover potentially relevant studies. Such uncovered published articles were obtained using the Google scholar search engine. Exclusion criteria  Non scholarly articles like news paper publications were not considered.  Conference abstracts and other publications that did not meet the above criteria were not included Results
Non Electronic sources:

Health care financing in Nigeria:
The Nigerian health system is generally funded from federation account to the states and LGAs, both of which also generate about 20% internal revenue from taxes, rates and levies. The allocation of federal revenues is fixed by the Revenue Mobilisation Allocation and Fiscal Commission (RMAFC) and approved by the National Assembly for five years. The allocation formula assigns 48.5 percent to the federal government, 24 percent to the states and 20 percent to local government, with 7.5 percent retained for 'special' federally determined projects. Once set, the revenue sharing formula provides limited room for manoeuvres on fiscal policy. (8) In Nigeria, the financing of PHC come from different sources and from different financing agents as shown in figures 1 and 2. (9) As shown in figures 1 and 2 above, the most common source of healthcare financing in Nigeria is out-of pocket payment from households which is estimated at 70.3% and regarded as one of the highest in the world. This is followed by government financing with allocation from the Federation Account's general revenue allocated to the various levels of government based on an agreed revenue allocation formula. Due to low share of government in total health care expenditure and the presence of user fees in many public facilities, households are prone to bear most of the expenses in the event of any health shock. The catastrophic consequences thus push some into poverty, and aggravate the poverty of others.
Financing Immunization:
According to the National Immunization Policy, (1) funding of immunization services should be a collective responsibility of all tiers of government exploring the following sources of funds for the financing of immunization services on a sustainable basis: The federal government provides and pays for the traditional and other vaccines through the National Primary Health Care Development Agency (NPHCDA) and also provides immunization guidelines and technical support to the states and Local Government Areas (LGAs). (4) The States and
LGAs are responsible for funding and implementing immunization programs at the sub-national levels (4) These include provision of administrative manpower and logistics needed to deliver the vaccines to the end users at their respective domains.
Sources of funds for immunization:
In practice today, immunization is financed mainly from statutory budgetary allocation from the Federal, State and Local Government Areas and donor partners. A majority of the funding still comes from the government accounting for about 76% of the total funds, followed by GAVI (12%), EU (4%), WHO (3%) and UNICEF 3%. (10) Generally, as shown in (13) 
(Supplemental immunization activities)
A number of donors also made commitment towards immunization activities that were carried out within the last 3 years. The secured funding from donors as at 2010 is as shown in figure 3 (13) In 2013, the Bill and Melinda Gates Foundation finalized a $25 million agreement with the World Bank to support the purchase of more than 100 million doses of oral polio vaccine (OPV) for Nigeria (14) Furthermore, the GAVI Alliance also approved the sum of US$ 21 million to help improve vaccine supply chains in Nigeria as part of a partnership aimed at scaling up routine immunization. The funds will be used by Nigeria's National Primary Health Care Development Agency to procure vital equipment for storing vaccines and to improve data collection, both of which have been identified as key pillars in protecting children's lives as enshrined in the government's Saving One Million Lives Initiative (15) Furthermore, the total commitments as of September 2013 amount to US$ 698 million, out of which US$ 438 million have been approved and US$ 241 million have been disbursed. Nigeria has submitted an application for a second phase of HSS support with a country ceiling of US$ 100 million over five years, effective from 2014 (15) .
On the whole these funds are disproportionately captured by the rich at the expense of the poor and by the urbanites the expense of the rural dwellers as depicted in the measles immunization coverage
Fig.4: Inequity in Measles immunization coverage
Financing bottlenecks in routine immunization:
Although strong support for RI is evident from the NPHCDA and the Federal Ministry of Health, and funds for RI have been consistently included in the federal budget, it is difficult to understand why financing for immunization remains a challenge, when it is largely accepted that immunization is among one of the "best buys" for the health sector, and that its financing is primarily a national public responsibility. Some of the bottlenecks include:
Inadequate funds:
Allocation to health from the federal budget has remained around 4-5% for the last decade, until it reached 6% in 2012, a far cry from the recommended 15%. Inadequate funding disrupts all aspects of supply and service delivery especially at the local level. The financing package comprises strategies to guarantee predictable government and flexible donor financing, including state-level basket funds, a recurrent federal budget line for vaccine procurement and financial guarantees from donors. In 2012, the Health Reform Foundation of Nigeria and International Vaccine Access Center (IVAC) held an interactive session with the Senate committee on Health to advocate for improved financing for immunization activities in the country and facilitate the reassignment of immunization from capital budget list to recurrent among other things. (16) With fiscal decentralization, states and
LGAs directly manage funding for RI implementation. Even when funds are budgeted for RI at the sub-national level, their timely release to
LGAs and Primary Healthcare Centers (PHCs) is not guaranteed. (4) Funding for RI is a major issue across all levels. The recent vaccine audit report indicated 76% of states and 65% of LGAs assessed did not have funds available for vaccine distribution (17) This limited availability of funds results in fluctuations in the supply of vaccines and devices to service delivery points, thus impacting on the RI coverage. Weak financial management and lack of fiscal oversight also compound the situation.
Delays in release of designated funds (at all levels):
There are federal and state budget line items for routine immunization, but the release of such funds is neither guaranteed nor timely (4) The same thing happens at the LGAs, and to an even greater extent here, provisions are made but funding disbursements are not. Delayed funding release during the 2011 fiscal year caused stock¬ outs. (4) In the Landscape analysis of routine immunization (LARI) in Nigeria by IVAC some respondents suggested funding vaccine procurement as a recurrent rather than a capital expense to avert the problem of delayed release of funds. Recurrent classification will likely regularize funds release, with the caveat that efforts to opti¬mize the recurrent/capital spending balance may target recurrent expenses. (4) Other options include donor-backed revolving funds or financial guarantees to avoid supply interruption when federal funds are delayed. At the national level, the timely release of adequate funding for vaccine procurement is crucial to avoiding any delay in delivery; yet disbursement can be affected due to budgetary approval delays. Thus, even though funds for procurement might be available, irregular disbursement can impact the vaccine supply chain with a detrimental effect on immunization coverage.
Inefficient use of funds:
Even when funds are adequate and released in good time, there is still gross inefficiency in the utilization of funds for RI. This was a main finding in the IVAC study on Landscape analysis of RI in Nigeria (4) Non-sustainable financing by donors:
It seems likely that key donors and international organizations will continue to contribute to the immunization program. However, some fluctuations in funding have been observed over the last five years with the likelihood that some may be planning to phase out of the programme altogether. For example EU Prime, ended its project by 2009 leaving a funding gap. The strategies for exit should focus on alternatives for funding these areas of cost covered by the exiting donor.
Poor coordination between RI and PEI:
The global drive to eradicate polio has resulted in polio eradication activities being executed in tandem, and sometimes in competition with, RI programs. Supplemental Immunization Activities (SIAs) for polio also occur multiple times per year. Rather than being integrated with RI programs, PEI tend to attract resources away from other immunization activities as the PEI activities are more likely to have financial incentives attachedhaving significant impact on the success of RI programs, particularly in low resource states and LGAs (18) NRISP, 2013-2015).
Appropriation of RI-designated funds for non-RI projects:
This is closely related to that discussed above.
There are instances where funds designated for RI are diverted to non-RI projects showing an absolute lack of financial accountability
Non Profitability of Vaccines:
Most developing countries have difficulties affording vaccines. International initiatives such as the Global Alliance for Vaccines and Immunization (GAVI) have the much needed funding that have helped increase immunization coverage and the number of vaccines provided. Vaccines are much less profitable than medicines, and thus pharmaceutical firms are understandably reluctant to make the huge investments necessary to develop vaccines against infectious diseases, realizing that the largest pool of potential customers are governments that likely will not afford to pay enough for these products to ensure a profit. (19) Accountability challenges:
Accountability has been simply defined as answerability between sets of actors in relation to specific activities or interventions (20) Undefined roles and responsibilities within the RI system greatly impact ownership and accountability. The overall health system is managed in silos, with unclear linkages across the different levels of government (federal, zonal, state, LGA and ward) that play a role in the delivery of PHC in Nigeria. Poor accountability among the workforce, especially at the states and LGAs, Limited feedback and accountability for outcomes at and between levels means there is little incentive to improve the current state of RI in the country. Nigeria will benefit from the deployment of an accountability framework that will lead to results-based performance monitoring, redefining of roles and responsibilities, alignment of resources, and transparent reporting and data management. (18) One of the presenters at the roundtable on Accountability framework for RI in Nigeria cited a Ugandan study, which showed that accountability interventions do work and that both quality and quantity of health services provision improved with implementation of accountability interventions. The study also reported an increase in weight of infants and a reduction in the number of under-five deaths due to the institution of an accountability framework. (20) Some of the other accountability challenges include a disconnect of responsibility and authority due to the concurrency of responsibility for health by all levels of government.
Government led initiatives to address key bottlenecks:
The federal Government has instituted some initiatives to address the key bottlenecks and these included: 
Solutions to the bottlenecks and accountability challenges:
The solutions to these bottlenecks must be implemented at the state and LGA level, because most barriers are occurring in these areas. To help mitigate the above mentioned financing and accountability problems the following are recommended: 
Conclusion
Strong financial support for immunization is evident from Federal Ministry of Health and donors. However, there are financing bottlenecks and accountability challenges to be addressed. When the National Health Bill becomes law, the bill will act as a rapid propellant to strengthening the Nigerian health system. In particular, it has provisions that will substantially increase the level of financial resources that will be available to fund primary health care services managed by the Local Government Areas.
Although in the aspect dealing with accountability we have tried to focus on harmonization and reporting we did not link financing (improved funding) to immunization services coverage which could help tell the story better. We acknowledge this as a limitation of the study and this could explored in further reviews.
